Abstract

PHARMACOTHERAPEUTIC APPROACHES AND COMMUNICATION STRATEGIES FOR THE MANAGEMENT OF NOVAL CORONA VIRUS-A SYSTEMATIC REVIEW

Dona Maria Jetto, Jeethu Joby*, Anusha Shaji, Anu Sebastian and Merrin Joseph

Abstract

The outbreak of COVID-19 was originated from Wuhan in December 2019 which turned into a serious threat to global public health. The studies state that the host of this virus was an animal which was sold at the seafood wholesale market in Wuhan. Coronavirus belongs to large family of viruses that are zoonotic in nature Among these COVID-19 patients, most of them have the common symptoms including fever, cough, and myalgia or fatigue at onset. World Health Organization (WHO) has declared corona virus disease 2019 (COVID-19) as a Public Health Emergency of International Concern and released interim guidelines on patient management. In the destitute of definitive and specific treatment regimens, strategies including early diagnosis, timely reporting, isolation, and supportive treatments are important line of actions against COVID-19 infections. In this review we have collected the epidemiological data and also summarized the drugs like Lopinavir/Ritonavir, Chloroquine, Oseltamivir, Remdesivir, Tocilizumab and Favipiravir. Here we present considerations in regard to the influence of masks on communication strategies. For the better analyzing of this novel corona virus, more research needs to be done to get better strategies for the management of COVID-19.

Keywords: COVID-19, Coronavirus, Wuhan, Chloroquine, Lopinavir/Ritonavir, Oseltamivir, Remdesivir, Tocilizumab, Favipiravir, Communication strategies.